Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Dashwood

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 12, 2018
Why 'EXTENT' for coronary artery bypass surgery when the saphenous vein should need no support?Michael R Dashwood
Brazilian Journal of Cardiovascular Surgery|November 19, 2025
Keeping NO in No-Touch Saphenous Vein Bypass GraftsMichael R Dashwood
Brazilian Journal of Cardiovascular Surgery|September 2, 2022
No-Touch Saphenous Vein - Vascular Damage and the London ConnectionMichael R Dashwood
Current Vascular Pharmacology|April 11, 2025
Saphenous Vein Coronary Artery Bypass Grafts: Why Invest in VEST?Michael R Dashwood
Current Vascular Pharmacology|February 12, 2016
Editorial: Endothelium: A Target for Therapeutic InterventionMichael R Dashwood
The New England Journal of Medicine|May 30, 2019
Endoscopic versus Open Vein-Graft Harvesting for CABGMichael R Dashwood
The Annals of Thoracic Surgery|November 27, 2012
Distension of the saphenous vein during graft preparation: markers of inflammation or endothelium?Michael R Dashwood
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|March 29, 2017
Neointima development in externally stented saphenous vein grafts. External stents are bad for the patient: why not use an undamaged saphenous vein for coronary artery bypass graft?Michael R Dashwood, Andrzej Loesch
The Journal of Thoracic and Cardiovascular Surgery|October 19, 2016
Three arteries versus the saphenous vein for coronary artery bypass graft: Why use a damaged graft to repair a damaged heart?Andrzej Loesch, Michael R Dashwood
Current Vascular Pharmacology|January 20, 2009
Neural control of the vasculature: pharmacological targets in vascular diseaseAndrzej Loesch, Michael R Dashwood
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 12, 2018
Why 'EXTENT' for coronary artery bypass surgery when the saphenous vein should need no support?Michael R Dashwood
Brazilian Journal of Cardiovascular Surgery|November 19, 2025
Keeping NO in No-Touch Saphenous Vein Bypass GraftsMichael R Dashwood
Brazilian Journal of Cardiovascular Surgery|September 2, 2022
No-Touch Saphenous Vein - Vascular Damage and the London ConnectionMichael R Dashwood
Current Vascular Pharmacology|April 11, 2025
Saphenous Vein Coronary Artery Bypass Grafts: Why Invest in VEST?Michael R Dashwood
Current Vascular Pharmacology|February 12, 2016
Editorial: Endothelium: A Target for Therapeutic InterventionMichael R Dashwood
The New England Journal of Medicine|May 30, 2019
Endoscopic versus Open Vein-Graft Harvesting for CABGMichael R Dashwood
The Annals of Thoracic Surgery|November 27, 2012
Distension of the saphenous vein during graft preparation: markers of inflammation or endothelium?Michael R Dashwood
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|March 29, 2017
Neointima development in externally stented saphenous vein grafts. External stents are bad for the patient: why not use an undamaged saphenous vein for coronary artery bypass graft?Michael R Dashwood, Andrzej Loesch
The Journal of Thoracic and Cardiovascular Surgery|October 19, 2016
Three arteries versus the saphenous vein for coronary artery bypass graft: Why use a damaged graft to repair a damaged heart?Andrzej Loesch, Michael R Dashwood
Current Vascular Pharmacology|January 20, 2009
Neural control of the vasculature: pharmacological targets in vascular diseaseAndrzej Loesch, Michael R Dashwood
Pageof 8